The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Asthma News
Asthma News - December 22, 2025
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails at MDHHS-Asthma@michigan.gov.
Check out the most recent MDHHS asthma social media messages and share them with your networks.
Inspiring Health Advances in Lung Care (INHALE): Formulary Assistance Guides
These formulary resources can help providers understand which medications are included in formularies. Also includes instructions for accessing the Managed Markets Insight & Technology (MMIT) formulary app on your phone and links to other formulary resources, including medication savings cards.
American Lung Association: Asthma Resource Library
This interactive library includes videos, toolkits, worksheets, infographics and other resources for asthma patients and caregivers.
MI Dept. of Health & Human Services: Thirdhand Smoke Infographic
"Thirdhand smoke” can worsen asthma symptoms and lead to asthma attacks. Learn more about the effects of this chemical residue left when smoke is no longer visible and smoke particles settle. Does airing out and vacuuming an area remove it?Barriers to Implementation of Single Maintenance and Reliever Therapy (SMART): Views From Pediatric Asthma Specialists
Despite US and international guidelines recommending SMART, there is substantial variation in its implementation among pediatric asthma specialists. Survey results indicate that pediatric asthma specialists are comfortable with its use, but that improvement in electronic medical record efficiency and consistent insurance coverage are needed to increase SMART adoption.Oral corticosteroid (OCS) reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
After 52 weeks of open-label tezepelumab treatment, nearly 90% of patients with OCS-dependent severe, uncontrolled asthma had a maintenance OCS dose of 5 mg per day or less and more than 50% completely discontinued OCS, while maintaining asthma control.
Maternal eating disorders and respiratory outcomes in childhood: findings from the EU Child Cohort Network
Maternal eating disorders are associated with a higher risk of wheezing and asthma in children, independently of comorbid depression/anxiety.